With COVID-19 and the question of whether glucocorticoids could be beneficial, this episode digs into the data on the use of glucocorticoids in the setting of infections, from pneumonia and septic arthritis, to meningitis and septic shock.

• Intro :11
• In this episode :25
• The first published case series of patients with serious infection 6:45
• Otolaryngologic infections 7:43
• Pneumonia, malaria and flu 8:26
• Cortisone in strep throat 9:22
• Major severe infections 11:26
• A review article 12:12
• Specific organ systems 13:25
• Dexamethasone for bacterial meningitis 25:28
• Septic shock 26:19
• Dearth of data on glucocorticoids for influenza 32:10
• Summary and take-home 35:19

Disclosure: Brown reports no relevant financial disclosures.

We'd love to hear from you! Send your comments/questions to [email protected]. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum

References:

Annane D, et al. JAMA. 2002;288:862-871.

Annane D, et al. N Engl J Med. 2018;378:809-818.

Bennett IL, et al. JAMA. 1963;183:462-465.

Blum CA, et al. Lancet. 2015;385:1511-1518.

de Gans J, van de Beek D. N Engl J Med. 2002;347:1549-1556.

Dellinger RP, et al. Crit Care Med. 2013;41:580-637.

Fogel I, et al. Pediatrics. 2015;136:e776.

Hahn EO, et al. J Clin Invest. 1951;30:274-281.

Hartman FA, Merle Scott WJ. Proc Soc Exp Biol and Med. 1931;28:478-479.

Hinshaw LB, et al. J Surg Res. 1980;28:151-170.

Nedel WL, et al. World J Crit Care Med. 2016;5:89-95.

Odio CM, et al. Pediatr Infect Dis J. 2003;22:883-888.

Perla D, Marmorston J. Endocrinology. 1940;27:368-374.

Stern A, et al. Cochrane Database Syst Rev. 2017;12:doi:10.1002/14651858.CD007720.pub3

Venkatesh B, et al. N Engl J Med. 2018;378:797-808.

Wenner WF, Cone AJ. Arch Otolaryngol. 1934;20:178-187.

Whitehead KW, Smith C. Proc Soc Expert Biol and Med. 1932;29:672-673.

Wysenbeek AJ, et al. Ann Rheum Dis. 1998;57:687–690.

Zhou Y, et al. Sci Rep. 2020;10:https://doi.org/10.1038/s41598-020-59732-7.